Grim side effects of weight loss drugs unemployed could be given in Labour scheme
The Government is considering using drugs to help get obese people back to work - but they can lead to serious health complications
7 common mistakes to avoid while taking popular weight loss drugs
StudyFinds' Dr. Faith Coleman looks at the common mistakes patients make using GLP-1 agonists like Ozempic and Wegovy.
Ozempic, Other Diabetes-Weight Loss Drugs Linked to 162 Deaths, According to FDA Data
Ozempic and other diabetes-weight loss drugs have been linked to at least 162 deaths and 10,000 cases involving “serious” injuries since
Britain to study use of Lilly's weight loss drug to get people back to work
Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high rate of long-term sickness that has become a major drag on the economy. Health minister Wes Streeting predicted the use of the drug - a competitor to Novo Nordisk's Ozempic - could help transform the health of the nation,
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
The U.K. is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with weight-loss treatment giant, Eli Lilly.
FDA will reconsider decision barring copycat versions of Lilly weight loss drug
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding pharmacies to continue selling their own versions.
Hims & Hers Stock Jumps as FDA Reconsiders Restrictions on Copycat Weight-Loss Drugs
Key Takeaways Hims & Hers shares gained Monday after the Food and Drug Administration said compounding pharmacies could continue to produce copycat weight-loss drugs while it reconsiders whether there is a shortage.
Hims & Hers up 10% as FDA reconsiders taking Lilly weight loss drug off shortage list
Hims & Hers Health (NYSE:HIMS) is up ~10% in Monday morning trading following a recent lawsuit challenging the U.S. FDA's  decision to remove Eli Lilly's (NYSE:LLY) tirzepatide from a drug shortages list.
Facebook has become the place to sell leftover Ozempic, other weight loss drugs — as NYC sellers take advantage of shortages and high prices
They’re due for a jab of justice. New Yorkers are brazenly reselling prescription diabetic and weight loss medications online ...
WXIX-TV20d
Nearly $270,000 in fake weight loss drugs seized in Cincinnati
CBP spokesperson Steven Bansbach says 63 shipments contained counterfeit and unapproved Ozempic, Wegovy, and Trulicity injections that are in high demand to help with weight loss. Ozempic is FDA ...
Yahoo21d
Counterfeit medications wanted for weight loss seized in Ohio
and Trulicity injections wanted for weight loss. Other medications discovered were Botox, Minoxidil, and Riaxon. New study: Does Ozempic work for long-term weight loss? According to the ...
pharmaphorum5d
Trulicity helps SGLT-2 patients lower blood sugar
New phase 3b trial results show Lilly’s Trulicity has helped type 2 diabetes patients already taking an SGLT2 inhibitor but whose blood sugar was inadequately controlled. The AWARD trial showed ...
Nasdaq1mon
Think Eli Lilly Stock Has Peaked? These 10 Words From the CEO May Change Your Mind
For years, Eli Lilly's business has relied heavily on top-selling diabetes drug Trulicity for growth. But with the approval of Mounjaro for diabetes and Zepbound for weight loss, it's a much ...
NBC Montana20d
Authorities seize nearly $270,000 worth of fake weight loss drugs in Cincinnati
CBP said its officers intercepted shipments that contained fake Ozempic, Wegovy and Trulicity injections, which are in high demand due to their success in aiding weight loss. The agency said it ...